sábado, 25 de abril de 2026

A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B In a Q&A, Venrock partner Bryan Roberts about a big-time deal By Allison DeAngelis, Adam Feuerstein, and Elaine ChenApril 24, 2026

https://www.statnews.com/2026/04/24/eli-lilly-kelonia-therapeutics-interview/

No hay comentarios: